Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines
about
Meningococcal B Vaccination (4CMenB) in Infants and ToddlersMeningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other PurposesPrevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infectionEmerging experience with meningococcal serogroup B protein vaccines.Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccinePredicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal.Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.Against vaccine assay secrecy.Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European CountriesCharacterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).Immunogenicity of a Meningococcal B Vaccine during a University Outbreak.A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program.Genome-based bacterial vaccines: current state and future outlook.Meningococcal vaccines: current issues and future strategies.Neisseria meningitidis B vaccines: recent advances and possible immunization policies.Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention.Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States.B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of in adolescentsPotential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Isolated from 2009 to 2013 in the Republic of IrelandPhase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine
P2860
Q26782285-30186A3D-BEA4-4643-B49F-0A664A056785Q26782318-1C10D9F1-CBCF-4004-B518-945A9112997CQ28080522-AE4CD3AF-54B7-4158-8FEC-BA2354764E19Q30234958-A1136A93-6005-4358-8E94-059165577848Q33600936-7CE2AAF1-0CAB-46D4-9B71-57F3C1BC0C08Q33620864-9C98F2A0-C658-4507-AEDF-DE89403F2E81Q33703560-BE0B4F32-8D59-4AC7-B66E-496B00B6D6EEQ35887486-3673640B-FCAF-43F3-95A7-DEA37B31EA12Q35947795-035B24B4-429C-4814-B6D3-F6D757764492Q36407498-F9B4FABE-D3FC-4E97-84EE-467D0529A1D2Q37192707-53B0E8EE-0BEB-454E-B7B3-F13F5EACC7ADQ37471668-A6C11D72-8AEC-40D3-868B-9F112CE84E2AQ38099207-85912BAE-F60B-40E4-ACD6-6430D106A340Q38120493-9C790C1E-DED1-4462-841C-4C627F6D2815Q38183156-F051E465-A6A5-464E-9A32-1BE98D28AA5DQ38210809-FE274C2B-0167-413D-A8AA-2EADB923ABDBQ38363907-5974AA80-3002-4892-9AD2-C86ACB1903F7Q41513468-B0B34F4D-3077-402D-9F9C-D43B837E8453Q45824896-8E74BFD3-6031-4BC9-AA48-C29FE0F8D1DCQ56526710-3A82202A-696A-4514-9A88-898CC1A93090Q57970428-03149921-CB31-4F9A-B76C-8A56C71D5052Q58701015-72896ED0-49CF-45BB-8E09-E4F47862495C
P2860
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Interlaboratory standardizatio ...... ge of investigational vaccines
@ast
Interlaboratory standardizatio ...... ge of investigational vaccines
@en
type
label
Interlaboratory standardizatio ...... ge of investigational vaccines
@ast
Interlaboratory standardizatio ...... ge of investigational vaccines
@en
prefLabel
Interlaboratory standardizatio ...... ge of investigational vaccines
@ast
Interlaboratory standardizatio ...... ge of investigational vaccines
@en
P2093
P2860
P50
P356
P1476
Interlaboratory standardizatio ...... ge of investigational vaccines
@en
P2093
Anna Carannante
Anne-Marie Klem
Brian D Plikaytis
Brunella Brunelli
Cecilia Fazio
Dominique A Caugant
Elisabeth Fritzsønn
George M Carlone
Giuseppe Boccadifuoco
P2860
P304
P356
10.1128/CVI.00202-12
P577
2012-08-08T00:00:00Z